传染科指南

订阅

MedSci主页 / 所有栏目 / 传染科指南

2020 WHO综合指南：结核病——耐药性结核病的治疗

2020-06-15 世界卫生组织 WHO官网

耐药性结核病

2020年6月，世界卫生组织(WHO)发布了结核病的综合指南，本文为该指南中关于耐药性结核病的治疗内容。耐药性结核病比药物敏感性结核病更难治疗，本文主要针对耐药性结核病的治疗提供指导建议

中文标题：

2020 WHO综合指南：结核病——耐药性结核病的治疗

英文标题：

WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment

发布机构：

世界卫生组织

发布日期：

2020-06-15

简要介绍：

2020年6月，世界卫生组织(WHO)发布了结核病的综合指南，本文为该指南中关于耐药性结核病的治疗内容。耐药性结核病比药物敏感性结核病更难治疗，本文主要针对耐药性结核病的治疗提供指导建议

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 WHO综合指南：结核病——耐药性结核病的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ed3a91c00210305e, title=2020 WHO综合指南：结核病——耐药性结核病的治疗, enTitle=WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment, guiderFrom=WHO官网, authorId=0, author=, summary=2020年6月，世界卫生组织(WHO)发布了结核病的综合指南，本文为该指南中关于耐药性结核病的治疗内容。耐药性结核病比药物敏感性结核病更难治疗，本文主要针对耐药性结核病的治疗提供指导建议, cover=https://img.medsci.cn/2021520/1621515324674_2020535.jpg, journalId=0, articlesId=null, associationId=138, associationName=世界卫生组织, associationIntro=null, copyright=0, guiderPublishedTime=Mon Jun 15 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p><span style="color: #373737;">2020年6月，世界卫生组织(WHO)发布了结核病的综合指南，本文为该指南中关于耐药性结核病的治疗内容。</span><span style="color: #373737;">耐药性结核病比药物敏感性结核病更难治疗，本文主要针对耐药性结核病的治疗提供指导建议</span></p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=89230, tagName=耐药性结核病)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=89230, guiderKeyword=耐药性结核病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6052, appHits=243, showAppHits=0, pcHits=1109, showPcHits=5809, likes=3, shares=17, comments=17, approvalStatus=1, publishedTime=Thu May 20 23:18:50 CST 2021, publishedTimeString=2020-06-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu May 20 20:55:33 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 06:48:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 WHO综合指南：结核病——耐药性结核病的治疗.pdf)])
2020 WHO综合指南：结核病——耐药性结核病的治疗.pdf
下载请点击：
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1197271, encodeId=56f8119e2719a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ff5641305, createdName=ms7000001516202991, createdTime=Fri Feb 25 17:38:16 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183248, encodeId=97da11832483b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b95182032, createdName=146fb74em01暂无昵称, createdTime=Tue Jan 11 16:07:02 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085464, encodeId=d53210854645a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e516424642, createdName=ms1000001708802022, createdTime=Wed Dec 29 15:20:56 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085462, encodeId=6cda10854628f, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e516424642, createdName=ms1000001708802022, createdTime=Wed Dec 29 15:18:24 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070266, encodeId=e7f710e02669d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=脊柱 doctor, createdTime=Sun Nov 14 22:29:20 CST 2021, time=2021-11-14, status=1, ipAttribution=)]
    2022-02-25 ms7000001516202991

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1197271, encodeId=56f8119e2719a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ff5641305, createdName=ms7000001516202991, createdTime=Fri Feb 25 17:38:16 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183248, encodeId=97da11832483b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b95182032, createdName=146fb74em01暂无昵称, createdTime=Tue Jan 11 16:07:02 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085464, encodeId=d53210854645a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e516424642, createdName=ms1000001708802022, createdTime=Wed Dec 29 15:20:56 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085462, encodeId=6cda10854628f, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e516424642, createdName=ms1000001708802022, createdTime=Wed Dec 29 15:18:24 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070266, encodeId=e7f710e02669d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=脊柱 doctor, createdTime=Sun Nov 14 22:29:20 CST 2021, time=2021-11-14, status=1, ipAttribution=)]
    2022-01-11 146fb74em01暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1197271, encodeId=56f8119e2719a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ff5641305, createdName=ms7000001516202991, createdTime=Fri Feb 25 17:38:16 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183248, encodeId=97da11832483b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b95182032, createdName=146fb74em01暂无昵称, createdTime=Tue Jan 11 16:07:02 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085464, encodeId=d53210854645a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e516424642, createdName=ms1000001708802022, createdTime=Wed Dec 29 15:20:56 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085462, encodeId=6cda10854628f, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e516424642, createdName=ms1000001708802022, createdTime=Wed Dec 29 15:18:24 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070266, encodeId=e7f710e02669d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=脊柱 doctor, createdTime=Sun Nov 14 22:29:20 CST 2021, time=2021-11-14, status=1, ipAttribution=)]
    2021-12-29 ms1000001708802022

    感谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1197271, encodeId=56f8119e2719a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ff5641305, createdName=ms7000001516202991, createdTime=Fri Feb 25 17:38:16 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183248, encodeId=97da11832483b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b95182032, createdName=146fb74em01暂无昵称, createdTime=Tue Jan 11 16:07:02 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085464, encodeId=d53210854645a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e516424642, createdName=ms1000001708802022, createdTime=Wed Dec 29 15:20:56 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085462, encodeId=6cda10854628f, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e516424642, createdName=ms1000001708802022, createdTime=Wed Dec 29 15:18:24 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070266, encodeId=e7f710e02669d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=脊柱 doctor, createdTime=Sun Nov 14 22:29:20 CST 2021, time=2021-11-14, status=1, ipAttribution=)]
    2021-12-29 ms1000001708802022

    感谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1197271, encodeId=56f8119e2719a, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3ff5641305, createdName=ms7000001516202991, createdTime=Fri Feb 25 17:38:16 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183248, encodeId=97da11832483b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21b95182032, createdName=146fb74em01暂无昵称, createdTime=Tue Jan 11 16:07:02 CST 2022, time=2022-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085464, encodeId=d53210854645a, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e516424642, createdName=ms1000001708802022, createdTime=Wed Dec 29 15:20:56 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085462, encodeId=6cda10854628f, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e516424642, createdName=ms1000001708802022, createdTime=Wed Dec 29 15:18:24 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070266, encodeId=e7f710e02669d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=498f5518383, createdName=脊柱 doctor, createdTime=Sun Nov 14 22:29:20 CST 2021, time=2021-11-14, status=1, ipAttribution=)]
    2021-11-14 脊柱 doctor

    不错

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2019 WHO综合指南：耐药结核的治疗

世界卫生组织(WHO,The World Health Organization) · 2019-04-01

2016意大利儿童耐药结核病治疗推荐

意大利儿童结核研究组 · 2016-02-08

拓展阅读

2016意大利儿童耐药结核病治疗推荐

意大利儿童结核研究组 · 2016-02-08

2019 WHO综合指南：耐药结核的治疗

世界卫生组织(WHO,The World Health Organization) · 2019-04-01